DIFFUSE PANBRONCHIOLITIS

This adverse event was reported 55 times

DIFFUSE PANBRONCHIOLITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIPTORELIN 2 0.0006
1 CLARITHROMYCIN 11 0.0003
2 LEVALBUTEROL HYDROCHLORIDE 1 0.0003
3 HYDROCORTISONE SODIUM SUCCINATE 1 0.0003
4 ERYTHROMYCIN 4 0.0002
5 TOBRAMYCIN SOLUTION 2 0.0002
6 THEOPHYLLINE ANHYDROUS 2 0.0002
7 TOBRAMYCIN SULFATE 2 0.0002
8 RAMUCIRUMAB 1 0.0002
9 TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM 1 0.0001
See all drugs enriched for association with DIFFUSE PANBRONCHIOLITIS